These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation. Schulman JD; Lustberg TJ; Kennedy JL; Museles M; Seegmiller JE Am J Med; 1970 Jul; 49(1):118-24. PubMed ID: 5431474 [No Abstract] [Full Text] [Related]
5. An 11-day-old boy with lethargy, poor feeding, vomiting. Maple syrup urine disease. Charrow J Pediatr Ann; 2005 Oct; 34(10):772-4. PubMed ID: 16285630 [No Abstract] [Full Text] [Related]
6. Intermittent branched chain ketonuria (variant of maple syrup urine disease). Irwin WC; Martel SB; Goluboff N Clin Biochem; 1971 Jun; 4(2):52-8. PubMed ID: 5128296 [No Abstract] [Full Text] [Related]
7. Electroencephalograms in a case of maple syrup urine disease: their relation to serum levels of branched-chain amino acids. Iinuma K; Saito T; Wada Y; Onuma A; Takamatsu N Tohoku J Exp Med; 1976 Oct; 120(2):191-5. PubMed ID: 982436 [TBL] [Abstract][Full Text] [Related]
8. Maple syrup urine disease in an infant with microgyria. Martin JK; Norman RM Dev Med Child Neurol; 1967 Apr; 9(2):152-9. PubMed ID: 6059316 [No Abstract] [Full Text] [Related]
11. Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity. Korein J; Sansaricq C; Kalmijn M; Honig J; Lange B Int J Neurosci; 1994 Nov; 79(1-2):21-45. PubMed ID: 7744549 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of maple syrup disease: a study of 36 patients. Morton DH; Strauss KA; Robinson DL; Puffenberger EG; Kelley RI Pediatrics; 2002 Jun; 109(6):999-1008. PubMed ID: 12042535 [TBL] [Abstract][Full Text] [Related]
13. Maple syrup urine disease: coenzyme function and prenatal monitoring. Elsas LJ; Priest JH; Wheeler FB; Danner DJ; Pask BA Metabolism; 1974 Jun; 23(6):569-79. PubMed ID: 4857216 [No Abstract] [Full Text] [Related]
14. [Neonatal leucinosis with favourable course. Therapeutic problems]. Astruc J; Froye E; Luciani JM; Bellet H; Magnan de Bornier P; Brunel D Ann Pediatr (Paris); 1977 Sep; 24(8-9):605-10. PubMed ID: 16211914 [No Abstract] [Full Text] [Related]
15. [3 patients with maple syrup urine disease]. Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657 [TBL] [Abstract][Full Text] [Related]
17. An early diagnosis leads to a good prognosis: a patient with maple syrup urine disease--screened by tandem mass spectrometry. Lin JF; Chiu PC; Hsu HY; Lin SM; Chen YY; Hsieh KS Acta Paediatr Taiwan; 2004; 45(5):287-9. PubMed ID: 15868812 [TBL] [Abstract][Full Text] [Related]
18. Prospective study of maple-syrup-urine disease for the first four days of life. DiGeorge AM; Rezvani I; Garibaldi LR; Schwartz M N Engl J Med; 1982 Dec; 307(24):1492-5. PubMed ID: 7144815 [No Abstract] [Full Text] [Related]
19. [Rapid separation of aromatic and ramified amino acids by chromatography on ion exchange columns. Application to the surveillance of leucinosis and hyperphenylalaninemia]. Rey F; Sivy M; Rey J Rev Eur Etud Clin Biol; 1972 Feb; 17(2):221-3. PubMed ID: 5055018 [No Abstract] [Full Text] [Related]
20. MAPLE SYRUP URINE DISEASE. VOYCE MA; MONTGOMERY JN; LYNCH GA; BOWMAN JK Br Med J; 1964 May; 1(5393):1293. PubMed ID: 14123637 [No Abstract] [Full Text] [Related] [Next] [New Search]